Discovery ofNovelLAT1-Targeted PET Tracers from 18F-Labeled AromaticAmino Acids via Photocatalyzed 18F-Fluorination

Abstract Positron emission tomography (PET) tracers targeting amino acid metabolic dysregulation offer unique advantages for diagnosing and monitoring malignant brain tumors. Though the large neutral amino acid transporter 1 (LAT1) serves as a biomarker for many malignancies, clinically applicable LAT1-targeted PET tracers remain limited. This study combines LAT1 structural information and efficient photocatalyzed 18F-deoxyfluorination to explore the structure-activity relationship (SAR) of unnatural aromatic amino acid-derived LAT1 ligands. Small hydrophobic alkyl/alkoxy substituents and diverse linkers were introduced to the phenyl ring to fit LAT1’s flexible hydrophobic binding domain, leading to the discovery of novel LAT1-targeted tracers with excellent tumor uptake. The methylated phenylalanine PET tracer L-[18F]1j (SUVmax = 1.55 ± 0.16) showed better orthotopic glioma (U87MG mice) uptake and boundary delineation than the clinically used [18F]FET (SUVmax = 0.96 ± 0.22). Additionally, L-[18F]1j was successfully synthesized via a commercial automated synthesis module, demonstrating a high potential for clinical translation.